These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26621708)

  • 1. Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline.
    Schwarz F; Springer SA; Altheide TK; Varki NM; Gagneux P; Varki A
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):74-9. PubMed ID: 26621708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reply to Liu and Jiang: Maintenance of postreproductive cognitive capacity by inclusive fitness.
    Springer SA; Schwarz F; Altheide TK; Varki NM; Varki A; Gagneux P
    Proc Natl Acad Sci U S A; 2016 Mar; 113(12):E1591-2. PubMed ID: 26933219
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease CD33 rs3865444 variant does not contribute to cognitive performance.
    Liu G; Jiang Q
    Proc Natl Acad Sci U S A; 2016 Mar; 113(12):E1589-90. PubMed ID: 26933222
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of APOE and CD33 on Cognitive Decline.
    Hayden KM; Lutz MW; Kuchibhatla M; Germain C; Plassman BL
    PLoS One; 2015; 10(6):e0130419. PubMed ID: 26102276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alzheimer's disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool.
    Siddiqui SS; Springer SA; Verhagen A; Sundaramurthy V; Alisson-Silva F; Jiang W; Ghosh P; Varki A
    J Biol Chem; 2017 Sep; 292(37):15312-15320. PubMed ID: 28747436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic evidence for the evolution of human postmenopausal longevity.
    Hawkes K
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):17-8. PubMed ID: 26699495
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of CD33 as a genetic risk factor for Alzheimer's disease.
    Estus S; Shaw BC; Devanney N; Katsumata Y; Press EE; Fardo DW
    Acta Neuropathol; 2019 Aug; 138(2):187-199. PubMed ID: 30949760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.
    Walker DG; Whetzel AM; Serrano G; Sue LI; Beach TG; Lue LF
    Neurobiol Aging; 2015 Feb; 36(2):571-82. PubMed ID: 25448602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
    Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
    J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.
    Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD33 rs2455069 SNP: Correlation with Alzheimer's Disease and Hypothesis of Functional Role.
    Tortora F; Rendina A; Angiolillo A; Di Costanzo A; Aniello F; Donizetti A; Febbraio F; Vitale E
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD33 isoforms in microglia and Alzheimer's disease: Friend and foe.
    Eskandari-Sedighi G; Jung J; Macauley MS
    Mol Aspects Med; 2023 Apr; 90():101111. PubMed ID: 35940942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility.
    Raj T; Ryan KJ; Replogle JM; Chibnik LB; Rosenkrantz L; Tang A; Rothamel K; Stranger BE; Bennett DA; Evans DA; De Jager PL; Bradshaw EM
    Hum Mol Genet; 2014 May; 23(10):2729-36. PubMed ID: 24381305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion.
    Butler CA; Thornton P; Brown GC
    J Neurochem; 2021 Jul; 158(2):297-310. PubMed ID: 33720433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene conversions are frequent but not under positive selection in the Siglec gene families of primates.
    Zid M; Drouin G
    Genome; 2014 Jun; 57(6):317-25. PubMed ID: 25166301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD33 and SHP-1/
    Beckers L; Rashid M; Lee AJ; Chatila ZK; Tamucci KA; Talcoff RC; Hall JL; Bennett DA; Vardarajan BN; Bradshaw EM
    Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.